Current Ratio: A liquidity ratio that measures a company's ability to pay short-term obligations. Calculated as: Total Current Assets / Total Current Liabilities
Kymera Therapeutics, Inc. (KYMR) had Current Ratio of 10.34 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$65.00M |
|
$-61.21M |
|
-- |
|
$65.00M |
|
$140.61M |
|
$-75.61M |
|
$14.40M |
|
$-61.21M |
|
$-61.21M |
|
$-61.21M |
|
$-61.21M |
|
$-61.21M |
|
$-61.21M |
|
$-75.61M |
|
$-75.90M |
|
98.18M |
|
98.18M |
|
$-0.62 |
|
$-0.62 |
|
| Balance Sheet Financials | |
$737.26M |
|
$39.97M |
|
$908.18M |
|
$1.65B |
|
$71.33M |
|
$0.84M |
|
$64.86M |
|
$136.19M |
|
$1.51B |
|
$1.51B |
|
$1.51B |
|
82.79M |
|
| Cash Flow Statement Financials | |
$-142.91M |
|
$-122.80M |
|
$33.19M |
|
$362.81M |
|
$130.30M |
|
$-232.51M |
|
$34.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
|
Current Ratio |
10.34 |
-- |
|
-- |
|
0.00 |
|
0.00 |
|
100.00% |
|
-116.32% |
|
-116.32% |
|
-- |
|
-94.17% |
|
-94.17% |
|
$-143.81M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
3.25 |
|
27.69 |
|
-4.06% |
|
-4.06% |
|
-3.72% |
|
-4.05% |
|
$18.23 |
|
$-1.46 |
|
$-1.46 |
|